274 related articles for article (PubMed ID: 31826272)
1. Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature.
Asonitis N; Angelousi A; Zafeiris C; Lambrou GI; Dontas I; Kassi E
Horm Metab Res; 2019 Dec; 51(12):770-778. PubMed ID: 31826272
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
5. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review.
Shallis RM; Rome RS; Reagan JL
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e123-e129. PubMed ID: 29361495
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
[TBL] [Abstract][Full Text] [Related]
10. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels.
Uchimura K; Mokuno T; Nagasaka A; Hayakawa N; Kato T; Yamazaki N; Kobayashi T; Nagata M; Kotake M; Itoh M; Tsujimura T; Iwase K
Metabolism; 2002 Jul; 51(7):871-5. PubMed ID: 12077733
[TBL] [Abstract][Full Text] [Related]
12. Blunted parathyroid response to correction of hypercalcemia in subjects with squamous cell carcinoma.
Yap AS; Mortimer RH; Jacobi JM; Galligan JP; Perry-Keene DA; Khafagi FA
Horm Res; 1993; 40(5-6):222-6. PubMed ID: 8112724
[TBL] [Abstract][Full Text] [Related]
13. PTHrP-mediated hypercalcemia: causes and survival in 138 patients.
Donovan PJ; Achong N; Griffin K; Galligan J; Pretorius CJ; McLeod DS
J Clin Endocrinol Metab; 2015 May; 100(5):2024-9. PubMed ID: 25719931
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.
Song R; Bijay Y; Rizk SH; Cao S
Ann Med Surg (Lond); 2021 Aug; 68():102667. PubMed ID: 34401137
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia of malignancy and new treatment options.
Sternlicht H; Glezerman IG
Ther Clin Risk Manag; 2015; 11():1779-88. PubMed ID: 26675713
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
18. Primary multifocal lymphoma of bone presenting as hypercalcemic crisis: report of a rare manifestation of extranodal lymphoma.
Evron E; Goland S; Klepfish A; Malnick SD; Sokolowski N; Sthoeger ZM
Leuk Lymphoma; 1999 Jun; 34(1-2):197-200. PubMed ID: 10350350
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid-hormone-related peptide in hematologic malignancies.
Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
[TBL] [Abstract][Full Text] [Related]
20. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
